Estimating the epidemic potential of SARS-CoV-2 Omicron variant in South Korea

Researchers in South Korea and France have conducted an analysis on individuals infected with Omicron variant (B.1.1.529) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to estimate the epidemic potential and long-term prospects of this virus in circulation. They have found that the basic reproduction number (R0) for this variant is 1.90, while the mean serial interval is 2.22 days.

The observations from the current study on the Omicron variant, when compared to that reported for delta variant in a previous South Korean study, suggest that the Omicron variant is more transmissible and likely possesses faster spreading potential in the community.

Study: Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea. Image Credit: Orpheus FX / Shutterstock.com

Study: Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea. Image Credit: Orpheus FX / Shutterstock.com

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Basic reproduction number and serial interval

R0 represents the average number of new cases generated directly from one infectious person in a completely susceptible population, i.e., in the absence of effective vaccines or control measures. It is an epidemiologic metric that indicates the transmission potential of infectious agents. If R0 > 1, the epidemic will spread, and if R0 < 1, the epidemic will not spread.

Serial interval refers to the time interval between successive cases. It is estimated from the time of symptom onset in primary/index case to the time of symptom onset in secondary case. Like R0, serial interval is another important epidemiological measure that serves as an important parameter in epidemic transmission models used to design infection control strategies.

A pre-print version of the study has been published on the medRxiv* server, while the article undergoes peer review.

Transmission chain (A) and epidemic curve (B) of laboratory-confirmed SARS- CoV-2 Omicron variant infection associated with the church (n=74) in South Korea.

Transmission chain (A) and epidemic curve (B) of laboratory-confirmed SARS- CoV-2 Omicron variant infection associated with the church (n=74) in South Korea.

Background

Towards the end of November 2021, World Health Organization (WHO) designated the new SARS-CoV-2 variant B.1.1.529 a variant of concern and named it Omicron. While delta continues to be the dominant SARS-CoV-2 variant prevalent worldwide, the emergence of the new variant Omicron (B.1.1.529 ) is causing serious concerns among the public health authorities due to the reports on its heavily mutated spike protein that could have unexpected consequences.

Nevertheless, the transmission potential of the Omicron variant in comparison to the Delta variant remains unclear. Therefore, to throw more light on the epidemiological transmission capacity of the new variant, the team conducted the present study in South Korea, which is currently experiencing the community transmission of the SARS-CoV-2 Omicron variant (B.1.1.529).

What did the researchers do?

The team aimed to estimate the serial interval and basic reproduction number (R0), involved in the community transmission of the Omicron variant in South Korea.

The study was based on publicly available data on cases of the Omicron variant from the South Korean public health authorities. Data were collected from November 25, 2021 – December 16, 2021, when the community transmission initiated in South Korea originating from the imported cases.

Contact tracing data and demographic characteristics of the cases, including age, the suspected source of infection, and date of symptom onset were collected. Serial interval distribution was estimated by fitting a normal distribution. To calculate R0, serial interval distribution acquired from the data was used as a proxy of generation time distribution.

Study findings

Of the total 131 cases associated with Omicron, 31% (n=23) of the cases had already received two doses of SARS-CoV-2 vaccination and were confirmed breakthrough coronavirus disease 19 (COVID-19) infection instances. Eighteen transmission pairs were identified with a known date of symptom onset for both primary and secondary cases.

Estimated serial interval distribution of the SARS-CoV-2 Omicron variant. The solid line indicates a fitted normal distribution.Estimated serial interval distribution of the SARS-CoV-2 Omicron variant. The solid line indicates a fitted normal distribution.

The mean serial interval was estimated to be 2.22 days (95% Credible Interval [CrI], 1.48–2.97), and the standard deviation of the serial interval estimate was found to be 1.62 days (95% CrI, 0.87–2.37). The R0 for the Omicron variant outbreak in South Korea was estimated to be 1.90 (95% CrI 1.50–2.43).

A previous Korean study on the Delta variant had observed the mean serial interval to be 3.3 days and R0 to be 1.0. The comparison between the two studies indicated that the Omicron variant is much more transmissible. Therefore, strict COVID-19 specific control measures and COVID-19 vaccination remain essential elements to reduce the community transmission of the Omicron variant.

Limitations

As of early December 2021, eighty percent of the Korean population had received two doses of COVID-19 vaccination. However, the current study did not analyze the impact of COVID-19 vaccination against transmission. Therefore the results might not show the exact scenario that would occur in a completely susceptible population and would not be generalizable for resource-limited countries.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 10 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Namita Mitra

Written by

Namita Mitra

After earning a bachelor’s degree in Veterinary Sciences and Animal Health  (BVSc) in 2013, Namita went on to pursue a Master of Veterinary Microbiology from GADVASU, India. Her Master’s research on the molecular and histopathological diagnosis of avian oncogenic viruses in poultry brought her two national awards. In 2013, she was conferred a doctoral degree in Animal Biotechnology that concluded with her research findings on expression profiling of apoptosis-associated genes in canine mammary tumors. Right after her graduation, Namita worked as Assistant Professor of Animal Biotechnology and taught the courses of Animal Cell Culture, Animal Genetic Engineering, and Molecular Immunology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Namita Mitra, Namita Mitra. (2023, May 10). Estimating the epidemic potential of SARS-CoV-2 Omicron variant in South Korea. News-Medical. Retrieved on November 07, 2024 from https://www.news-medical.net/news/20211228/Estimating-the-epidemic-potential-of-SARS-CoV-2-Omicron-variant-in-South-Korea.aspx.

  • MLA

    Namita Mitra, Namita Mitra. "Estimating the epidemic potential of SARS-CoV-2 Omicron variant in South Korea". News-Medical. 07 November 2024. <https://www.news-medical.net/news/20211228/Estimating-the-epidemic-potential-of-SARS-CoV-2-Omicron-variant-in-South-Korea.aspx>.

  • Chicago

    Namita Mitra, Namita Mitra. "Estimating the epidemic potential of SARS-CoV-2 Omicron variant in South Korea". News-Medical. https://www.news-medical.net/news/20211228/Estimating-the-epidemic-potential-of-SARS-CoV-2-Omicron-variant-in-South-Korea.aspx. (accessed November 07, 2024).

  • Harvard

    Namita Mitra, Namita Mitra. 2023. Estimating the epidemic potential of SARS-CoV-2 Omicron variant in South Korea. News-Medical, viewed 07 November 2024, https://www.news-medical.net/news/20211228/Estimating-the-epidemic-potential-of-SARS-CoV-2-Omicron-variant-in-South-Korea.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans